HM Payson & Co’s Pulmonx LUNG Stock Holding History

HM Payson & Co’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-310	Closed	-$14K	–	1131
2021 Q1	$14K	Hold	310	–	–	﹤0.01%	829
2020 Q4	$21K	Buy	+310	New	+$15.2K	﹤0.01%	763

Other funds holding LUNG

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

HM Payson & Co's LUNG Position: Q2 2021 in Review

HM Payson & Co sold out of Pulmonx (LUNG) in Q2 2021, closing a stake of 310 shares — an estimated $14K sold.

HM Payson & Co first reported a position in LUNG in Q4 2020 and held it in 2 quarters. The position peaked at $21K in Q4 2020. 113 funds tracked by Wall St. Rank hold LUNG as of Q2 2021.

HM Payson & Co reported no remaining Pulmonx position as of Q2 2021 after selling out during the quarter.
HM Payson & Co sold 310 Pulmonx shares in Q2 2021, an estimated $14K.
HM Payson & Co first reported a position in Pulmonx in Q4 2020 and held it in 2 quarters.
HM Payson & Co's Pulmonx position peaked at $21K in Q4 2020.
113 funds tracked by Wall St. Rank held Pulmonx as of Q2 2021.

Based on HM Payson & Co's 13F filing for Q2 2021, filed 17 Aug 2021.